title: Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors.
abstract: Transforming growth factor-beta (TGF-beta) is a ubiquitous cytokine with dual roles in tumor suppression and promotion, and these dichotomous functions have frustrated the development of therapies targeting oncogenic signaling by TGF-beta. In comparison, Abl is well established as an initiator of hematopoietic cancers; however, a clear role for Abl in regulating solid tumor development remains elusive. Here, we investigated the role of Abl in TGF-beta-mediated epithelial-mesenchymal transition (EMT) in normal and metastatic mammary epithelial cells (MECs). In doing so, we identified Abl as an essential regulator of MEC morphology and showed that Abl inactivation was sufficient to induce phenotypic and transcriptional EMT in normal MECs. Increasing Abl activity in metastatic MECs resulted in their complete morphological reversion, restored their cytostatic response to TGF-beta, and blocked their secretion of matrix metalloproteinases induced by TGF-beta. Constitutively active Abl expression blocked TGF-beta-responsive mammary tumor growth in mice, while Imatinib therapy afforded no clinical benefit in mice bearing mammary tumors. Collectively, this investigation establishes Abl as a potent mediator of MEC identity, and as a suppressor of oncogenic TGF-beta signaling during mammary tumorigenesis. Notably, our findings strongly caution against the use of pharmacological Abl antagonists in the treatment of developing and progressing mammary tumors.
authors.affiliation: Department of Pharmacology, MS-8303, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045, USA.
authors.forename: Tressa M
authors.initials: TM
authors.lastname: Allington
authors.forename: Amy J
authors.initials: AJ
authors.lastname: Galliher-Beckley
authors.forename: William P
authors.initials: WP
authors.lastname: Schiemann
mesh_terms: D000818:Animals; D001549:Benzamides; D045744:Cell Line, Tumor; D004847:Epithelial Cells; D005260:Female; D000068877:Imatinib Mesylate; D008321:Mammary Glands, Animal; D015674:Mammary Neoplasms, Animal / Q000378:metabolism*; D045726:Metalloproteases / Q000235:genetics / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D010879:Piperazines; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D011743:Pyrimidines; D015398:Signal Transduction / Q000502:physiology*; D016212:Transforming Growth Factor beta / Q000235:genetics / Q000378:metabolism*
chemical_list: D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D016212:Transforming Growth Factor beta; D000068877:Imatinib Mesylate; D045726:Metalloproteases
references.citation: Cancer Metastasis Rev. 2009 Jun;28(1-2):113-27
references.pmid: 19153673
references.citation: Curr Biol. 2001 Nov 13;11(22):1759-65
references.pmid: 11719217
references.citation: Lancet Oncol. 2004 Apr;5(4):229-39
references.pmid: 15050954
references.citation: Biochim Biophys Acta. 2007 Jan;1775(1):21-62
references.pmid: 16904831
references.citation: BJU Int. 2006 Oct;98(4):763-9
references.pmid: 16796694
references.citation: J Mammary Gland Biol Neoplasia. 2001 Jan;6(1):67-82
references.pmid: 11467453
references.citation: Expert Rev Anticancer Ther. 2007 May;7(5):609-11
references.pmid: 17492924
references.citation: Cancer Lett. 2006 Feb 28;233(2):328-37
references.pmid: 15893416
references.citation: Cancer Res. 2006 Jun 1;66(11):5648-55
references.pmid: 16740702
references.citation: Cell. 2008 May 16;133(4):704-15
references.pmid: 18485877
references.citation: J Biol Chem. 2006 Sep 22;281(38):27846-54
references.pmid: 16867995
references.citation: J Biol Chem. 2008 Aug 1;283(31):21394-403
references.pmid: 18480060
references.citation: Genes Dev. 2004 Aug 1;18(15):1875-85
references.pmid: 15289459
references.citation: Urology. 2007 Mar;69(3):526-31
references.pmid: 17382158
references.citation: Genes Dev. 1999 Sep 15;13(18):2400-11
references.pmid: 10500097
references.citation: Oncogene. 2007 Nov 15;26(52):7313-23
references.pmid: 17533370
references.citation: Adv Cancer Res. 2002;85:51-100
references.pmid: 12374288
references.citation: Curr Opin Cell Biol. 1996 Apr;8(2):174-81
references.pmid: 8791414
references.citation: Curr Med Chem. 2001 Mar;8(4):425-74
references.pmid: 11172697
references.citation: Cancer Sci. 2007 Oct;98(10):1512-20
references.pmid: 17645776
references.citation: Breast Cancer Res Treat. 2005 Mar;90(2):157-63
references.pmid: 15803362
references.citation: Proc Am Thorac Soc. 2008 Apr 15;5(3):316-22
references.pmid: 18403326
references.citation: Cancer Res. 1987 Jun 15;47(12):3239-45
references.pmid: 2438036
references.citation: Clin Genitourin Cancer. 2007 Jun;5(5):323-8
references.pmid: 17645829
references.citation: Oncogene. 2008 Feb 14;27(8):1095-105
references.pmid: 17700528
references.citation: J Biol Chem. 2008 Aug 1;283(31):21382-93
references.pmid: 18480061
references.citation: Breast Cancer Res. 2000;2(2):125-32
references.pmid: 11250702
references.citation: Clin Breast Cancer. 2008 Dec;8(6):511-5
references.pmid: 19073506
references.citation: Nature. 2005 Jul 7;436(7047):123-7
references.pmid: 16001073
references.citation: J Biol Chem. 2001 May 11;276(19):16185-92
references.pmid: 11279004
references.citation: Cold Spring Harb Symp Quant Biol. 2005;70:343-56
references.pmid: 16869771
references.citation: Curr Opin Cell Biol. 2003 Dec;15(6):740-6
references.pmid: 14644200
references.citation: Oncogene. 2008 Jul 24;27(32):4385-91
references.pmid: 18391983
references.citation: Cell Res. 2009 Feb;19(2):156-72
references.pmid: 19153598
references.citation: J Biol Chem. 2002 Jul 26;277(30):27367-77
references.pmid: 12021267
references.citation: Future Oncol. 2009 Mar;5(2):259-71
references.pmid: 19284383
references.citation: Clin Exp Metastasis. 2009;26(1):35-49
references.pmid: 18814043
references.citation: Cancer Cell. 2005 Jan;7(1):17-23
references.pmid: 15652746
references.citation: Oncogene. 2009 Mar 12;28(10):1285-97
references.pmid: 19151753
references.citation: Ann Oncol. 2008 Oct;19(10):1713-9
references.pmid: 18515258
references.citation: Expert Rev Anticancer Ther. 2008 Jun;8(6):853-64
references.pmid: 18533795
references.citation: FASEB J. 2005 Jan;19(1):1-11
references.pmid: 15629889
references.citation: Curr Opin Cell Biol. 2004 Oct;16(5):558-64
references.pmid: 15363807
references.citation: Nat Cell Biol. 2006 Aug;8(8):815-25
references.pmid: 16862147
references.citation: Cancer Res. 2008 Mar 1;68(5):1462-70
references.pmid: 18316610
references.citation: Curr Med Chem. 2004 Nov;11(22):2911-77
references.pmid: 15544483
references.citation: Pancreas. 2008 May;36(4):341-5
references.pmid: 18437079
references.citation: Laryngoscope. 2006 Aug;116(8):1390-6
references.pmid: 16885742
references.citation: Cell Cycle. 2008 Feb 15;7(4):444-8
references.pmid: 18235247
references.citation: Mol Biol Cell. 2003 Oct;14(10):3977-88
references.pmid: 14517312
references.citation: J Biol Chem. 2001 Jul 20;276(29):27104-10
references.pmid: 11309382
references.citation: Carcinogenesis. 2008 Dec;29(12):2243-51
references.pmid: 18713838
references.citation: Carcinogenesis. 2008 Feb;29(2):244-51
references.pmid: 18174260
references.citation: J Cell Physiol. 2007 Apr;211(1):19-26
references.pmid: 17167774
references.citation: Nat Rev Cancer. 2009 Feb;9(2):108-22
references.pmid: 19165226
references.citation: Clin Exp Metastasis. 2008;25(8):865-70
references.pmid: 18709334
references.citation: Proc Natl Acad Sci U S A. 1975 Sep;72(9):3585-9
references.pmid: 1059147
references.citation: Nat Cell Biol. 2006 Aug;8(8):785-6
references.pmid: 16880809
references.citation: Cancer Cell. 2005 Sep;8(3):241-54
references.pmid: 16169468
references.citation: J Cell Biol. 2004 May 24;165(4):493-503
references.pmid: 15148308
references.citation: Birth Defects Res C Embryo Today. 2006 Mar;78(1):1-10
references.pmid: 16622845
references.citation: J Cell Biol. 2002 Mar 4;156(5):879-92
references.pmid: 11864995
references.citation: Oncogene. 2001 Jul 19;20(32):4298-304
references.pmid: 11466610
references.citation: Curr Opin Genet Dev. 2002 Feb;12(1):22-9
references.pmid: 11790550
references.citation: J Clin Invest. 2004 Nov;114(9):1308-16
references.pmid: 15520863
references.citation: Int J Biochem Cell Biol. 2007;39(6):1082-8
references.pmid: 17416542
references.citation: Oncogene. 2001 Jun 28;20(29):3845-56
references.pmid: 11439348
references.citation: Biochem Biophys Res Commun. 2008 Jul 11;371(4):713-8
references.pmid: 18457660